12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2016
https://researcherprofiles.org/profile/1199218
27025835